Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07071129 · ClinicalTrials.gov registry record · NA
Virtual Reality for Enhancement of Vision
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT07071129: Clinical Trial NA study, sponsored by Stanford University.
NCT07071129 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07071129, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
This project aims to evaluate the use of Virtual Reality (VR) based visual stimulation for the treatment of blindness arising from Glaucoma and other retinal diseases or disorders of the visual system, through regeneration of axons of retinal ganglion cells (RGCs) in humans. In certain cases of blindness, such as in Glaucoma, or in certain injuries, the optic nerves behind the retina of our eyes get damaged, leading to partial blindness, mostly near the periphery of our eye. Recent research in Dr.Huberman's laboratory has identified visual stimulation as a non-invasive model for regeneration of such damaged axons in rodents, back to the vision centers of their brain.
Interventions
- DEVICE Virtual Reality Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2018-04-17 |
| Est. Completion | 2025-09-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07071129
The ClinicalTrials.gov registry entry for NCT07071129 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Virtual Reality Stimulation is the first listed.
NCT07071129 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07071129 about?
NCT07071129 is a clinical study titled "Virtual Reality for Enhancement of Vision". This project aims to evaluate the use of Virtual Reality (VR) based visual stimulation for the treatment of blindness arising from Glaucoma and other retinal diseases or disorders of the visual system, through regeneration of axons of retinal ganglion cells (RGCs) in humans. In certain cases of bli...
What is the current status of trial NCT07071129?
This trial is currently terminated. It is a NA study. The enrollment target is 22 participants. The study started on 2018-04-17. Estimated completion is 2025-09-07.
What interventions are being tested in trial NCT07071129?
The interventions under investigation include: Virtual Reality Stimulation (DEVICE).
Who is sponsoring clinical trial NCT07071129?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.